Skip to main content
. Author manuscript; available in PMC: 2009 Jul 14.
Published in final edited form as: Cancer Res. 2008 Apr 1;68(7):2286–2291. doi: 10.1158/0008-5472.CAN-07-1349

Figure 3.

Figure 3

HPN targeted peptides and nanoparticles are able to identify human prostate cancer. IPL-F or IPL-NP was incubated with tissue microarrays consisting of 6 normal and 5 cancer human radical prostatectomy specimens. Results shown are representative images. Panels A. and C show the binding of IPL-F/IPL-NP to cancer glands and panels B. and D. show the binding to benign glands (Original magnification of A and B, 20×; Original magnification of C and D, 60×). Note staining in the tumor cells and the absence/weak staining in benign tissues and stroma.